These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells. Anticoli S; Aricò E; Arenaccio C; Manfredi F; Chiozzini C; Olivetta E; Ferrantelli F; Lattanzi L; D'Urso MT; Proietti E; Federico M J Mol Med (Berl); 2018 Feb; 96(2):211-221. PubMed ID: 29282521 [TBL] [Abstract][Full Text] [Related]
5. Exosomes Enter Vaccine Development: Strategies Meeting Global Challenges of Emerging Infections. Jungbauer A Biotechnol J; 2018 Apr; 13(4):e1700749. PubMed ID: 29469213 [TBL] [Abstract][Full Text] [Related]
6. A strategy of antigen incorporation into exosomes: comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles. Lattanzi L; Federico M Vaccine; 2012 Nov; 30(50):7229-37. PubMed ID: 23099330 [TBL] [Abstract][Full Text] [Related]
7. Strong CD8+ T cell antigenicity and immunogenicity of large foreign proteins incorporated in HIV-1 VLPs able to induce a Nef-dependent activation/maturation of dendritic cells. Sistigu A; Bracci L; Valentini M; Proietti E; Bona R; Negri DR; Ciccaglione AR; Tritarelli E; Nisini R; Equestre M; Costantino A; Marcantonio C; Santini SM; Lapenta C; Donati S; Tataseo P; Miceli M; Cara A; Federico M Vaccine; 2011 Apr; 29(18):3465-75. PubMed ID: 21382480 [TBL] [Abstract][Full Text] [Related]
20. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]